1
|
Mittal G, R I A, Vatsyayan A, Pandhare K, Scaria V. MUSTARD-a comprehensive resource of mutation-specific therapies in cancer. DATABASE-THE JOURNAL OF BIOLOGICAL DATABASES AND CURATION 2021; 2021:6328507. [PMID: 34309639 PMCID: PMC8312254 DOI: 10.1093/database/baab042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 08/03/2020] [Revised: 06/22/2021] [Accepted: 06/28/2021] [Indexed: 12/09/2022]
Abstract
The steady increase in global cancer burden has fuelled the development of several modes of treatment for the disease. In the presence of an actionable mutation, targeted therapies offer a method to selectively attack cancer cells, increasing overall efficacy and reducing harmful side effects. However, different drug molecules are in different stages of development, with new molecules obtaining approvals from regulatory agencies each year. To augment clinical impact, it is important that this information reaches clinicians, patients and researchers swiftly and in a structured, well-annotated manner. To this end, we have developed Mutation-Specific Therapies Resource and Database in Cancer (MUSTARD), a database that is designed to be a centralized resource with diverse information such as cancer subtype, associated mutations, therapy offered and its effect observed, along with links to external resources for a more comprehensive annotation. In its current version, MUSTARD comprises over 2105 unique entries, including associations between 418 unique drug therapies, 189 cancer subtypes and 167 genes curated and annotated from over 862 different publications. To the best of our knowledge, it is the only resource that offers comprehensive information on mutation-specific, gene fusions and overexpressed gene-targeted therapies for cancer. Database URL: http://clingen.igib.res.in/mustard/
Collapse
Affiliation(s)
- Gauri Mittal
- Indraprastha Institute of Information Technology, Okhla Industrial Estate, Phase III, Delhi 110020, India
| | - Anu R I
- Department of Clinical Biochemistry, MVR Cancer Center and Research Institute, CP 13/516 B, C, Vellalasseri NIT(Via), Poolacode, Kozhikode 673601, India.,Cancer Biology and Therapeutics: High-Impact Cancer Research Post Graduate Program, Harvard Medical School, 4 Blackfan Circle, Boston, MA 02115, USA
| | - Aastha Vatsyayan
- Department of Genome Informatics, CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Mathura Road, Delhi 110025, India.,Academy of Scientific and Innovative Research (AcSIR), Sector 19, Kamla Nehru Nagar, Ghaziabad, UP 201002, India
| | - Kavita Pandhare
- Department of Genome Informatics, CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Mathura Road, Delhi 110025, India
| | - Vinod Scaria
- Department of Genome Informatics, CSIR Institute of Genomics and Integrative Biology (CSIR-IGIB), Mathura Road, Delhi 110025, India.,Academy of Scientific and Innovative Research (AcSIR), Sector 19, Kamla Nehru Nagar, Ghaziabad, UP 201002, India
| |
Collapse
|